SEYED EBRAHIM KASSAIAN to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications SEYED EBRAHIM KASSAIAN has written about Platelet Aggregation Inhibitors.
Connection Strength
0.557
-
Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors. Crit Pathw Cardiol. 2016 09; 15(3):89-94.
Score: 0.418
-
Clinical characteristics, management and 1-year outcomes of patients with acute coronary syndrome in Iran: the Iranian Project for Assessment of Coronary Events 2 (IPACE2). BMJ Open. 2015 12 15; 5(12):e007786.
Score: 0.099
-
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study. Anatol J Cardiol. 2015 May; 15(5):348-53.
Score: 0.024
-
In-hospital and mid-term adverse clinical outcomes of a direct stenting strategy versus stenting after pre-dilatation for the treatment of coronary artery lesions. Cardiovasc J Afr. 2008 Nov-Dec; 19(6):297-302.
Score: 0.015